Mindstate

Precision designed altered states of consciousness

Human 3 criteria:

AI enabled

Distribution shifting

Prior evidence of human use

Mindstate's AI-powered platform maps the biological basis of emotion, perception, and cognition. By combining over 60,000 human reports of psychoactive drug effects with biochemical data, Mindstate identifies how specific neurotransmitter receptor combinations produce distinct emotional and cognitive states. Mindstate uses this platform to develop novel psychoactive drugs to treat mental health conditions.

Under the radar for now - more info soon.

2021

XEIA invests

2024

Initiates Phase 1 clinical trial

Initiates Phase 1 clinical trial

Want more from XEIA?

Stay up to date on Human 3 - the new epoch of health, wellbeing and performance

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.
Thank you! You've been added to our mailing list.
Oops! Something went wrong while submitting the form.
X-disciplinary Exploration, Investment & Acceleration

© 2025 XEIA Venture Partners, LLC